120 related articles for article (PubMed ID: 37795527)
1. Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.
Ichikawa T; Tamura T; Takahata M; Ishio T; Ibata M; Kasahara I; Minauchi K; Yamamoto S; Teshima T; Fukuhara T
Br J Haematol; 2024 Mar; 204(3):815-820. PubMed ID: 37795527
[TBL] [Abstract][Full Text] [Related]
2. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
[TBL] [Abstract][Full Text] [Related]
3. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
Aguareles J; Villares Fernández P; Forné C; Martí-Ballesteros EM; Pradillo Fernández V; Sotres-Fernandez G; de la Fuente-Burguera A; Navarro-San Francisco C; Buzón-Martín LM; García-Delangue T; Aiello FT; Carnevali-Ruiz D; Lloris R; Luepke-Estefan XE; López-Martín JA; Jimeno JM; García-Casas A; Guisado-Vasco P
Infect Dis (Lond); 2024 Jul; 56(7):575-580. PubMed ID: 38743059
[TBL] [Abstract][Full Text] [Related]
5. Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID-19: A prospective cohort study.
Kang SW; Kim JW; Kim JY; Lim SY; Jang CY; Chang E; Yang JS; Kim KC; Jang HC; Kim D; Shin Y; Lee JY; Kim SH
J Med Virol; 2023 Nov; 95(11):e29228. PubMed ID: 38009999
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
7. Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa.
Meiring S; Tempia S; Bhiman JN; Buys A; Kleynhans J; Makhasi M; McMorrow M; Moyes J; Quan V; Walaza S; du Plessis M; Wolter N; von Gottberg A; Cohen C;
Clin Infect Dis; 2022 Aug; 75(1):e144-e156. PubMed ID: 35134129
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
[TBL] [Abstract][Full Text] [Related]
9. An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA.
Laferl H; Kelani H; Seitz T; Holzer B; Zimpernik I; Steinrigl A; Schmoll F; Wenisch C; Allerberger F
Infection; 2021 Feb; 49(1):95-101. PubMed ID: 33025521
[TBL] [Abstract][Full Text] [Related]
10. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9).
Cesaro S; Ljungman P; Mikulska M; Hirsch HH; von Lilienfeld-Toal M; Cordonnier C; Meylan S; Mehra V; Styczynski J; Marchesi F; Besson C; Baldanti F; Masculano RC; Beutel G; Einsele H; Azoulay E; Maertens J; de la Camara R; ; Pagano L
Leukemia; 2022 Jun; 36(6):1467-1480. PubMed ID: 35488021
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies.
Biernat MM; Zińczuk A; Biernat P; Bogucka-Fedorczuk A; Kwiatkowski J; Kalicińska E; Marciniak D; Simon K; Wróbel T
J Clin Virol; 2020 Sep; 130():104574. PubMed ID: 32769026
[TBL] [Abstract][Full Text] [Related]
12. The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study.
Sepulcri C; Dentone C; Mikulska M; Bruzzone B; Lai A; Fenoglio D; Bozzano F; Bergna A; Parodi A; Altosole T; Delfino E; Bartalucci G; Orsi A; Di Biagio A; Zehender G; Ballerini F; Bonora S; Sette A; De Palma R; Silvestri G; De Maria A; Bassetti M
Open Forum Infect Dis; 2021 Nov; 8(11):ofab217. PubMed ID: 34796242
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of In-Hospital Cluster of COVID-19 Associated With a Patient With Prolonged Viral Shedding Using Whole-Genome Sequencing.
Jung J; Lee J; Kim SK; Park S; Lim YJ; Kim EO; Park H; Park MS; Kim SH
J Korean Med Sci; 2022 Oct; 37(39):e289. PubMed ID: 36217571
[TBL] [Abstract][Full Text] [Related]
14. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
[TBL] [Abstract][Full Text] [Related]
15. Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study.
Long H; Zhao J; Zeng HL; Lu QB; Fang LQ; Wang Q; Wu QM; Liu W
BMC Infect Dis; 2021 Dec; 21(1):1282. PubMed ID: 34961470
[TBL] [Abstract][Full Text] [Related]
16. Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab.
Franceschini E; Pellegrino M; Todisco V; Dolci G; Bettelli F; Meschiari M; Bedini A; Fregni-Serpini G; Grottola A; Guaraldi G; Pecorari M; Sarti M; Luppi M; Perno CF; Mussini C
Infection; 2023 Oct; 51(5):1577-1581. PubMed ID: 37076752
[TBL] [Abstract][Full Text] [Related]
17. Prolonged SARS-CoV-2 shedding in a person living with advanced HIV and diffuse large B-cell lymphoma: a case report.
Maan I; Paraskevopoulou SM; Cwynarski K; Shrestha M; Waters L; Miller R; Ahmed N
Infect Dis (Lond); 2022 Jul; 54(7):529-533. PubMed ID: 35348397
[TBL] [Abstract][Full Text] [Related]
18. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection.
Abu Shanap M; Sughayer M; Alsmadi O; Elzayat I; Al-Nuirat A; Tbakhi A; Sultan I
Front Immunol; 2022; 13():919762. PubMed ID: 35990639
[TBL] [Abstract][Full Text] [Related]
19. Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
Minoia C; Diella L; Perrone T; Loseto G; Pelligrino C; Attolico I; Pasciolla C; Totaro V; De Candia MS; Spada V; Clemente F; Camporeale M; Di Gennaro F; Guarini A; Musto P; Saracino A; Bavaro DF
Br J Haematol; 2023 Sep; 202(5):928-936. PubMed ID: 37259629
[TBL] [Abstract][Full Text] [Related]
20. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]